Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Bio-Gene Technology Ltd. ( (AU:BGT) ) has provided an update.
Bio-Gene Technology Ltd has announced the quotation of 50,340,392 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from May 9, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the company’s visibility and accessibility in the financial markets.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Ltd operates in the biotechnology industry, focusing on the development and commercialization of novel insecticide products. The company aims to address the growing demand for effective pest control solutions while minimizing environmental impact.
Average Trading Volume: 181,697
Technical Sentiment Signal: Sell
Current Market Cap: A$4.63M
For an in-depth examination of BGT stock, go to TipRanks’ Stock Analysis page.